Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-22-000010 General Corporate
Debt relative to revenue 53th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
104.42% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
11.95% · OPTIONAL · VALID
Operating cash generation 21th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-17.81% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
59.63% · CORE · VALID
Inventory pressure 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
53.11% · OPTIONAL · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
9.07% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.68% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.33% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 33.33%
Current 104.42%
Delta 71.09% Capex Intensity Increased
Previous 10.28%
Current 11.95%
Delta 1.66% Cash Generation Decreased
Previous 8.88%
Current -17.81%
Delta -26.69% Growth Decreased
Previous 97.14%
Current 59.63%
Delta -37.51% Inventory Pressure Increased
Previous 17.02%
Current 53.11%
Delta 36.08% Profitability Increased
Previous 6.53%
Current 9.07%
Delta 2.53% R And D Intensity Decreased
Previous 2.17%
Current 1.68%
Delta -0.49% Sbc Intensity Increased
Previous 1.23%
Current 1.33%
Delta 0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.